BORUZU 3.5 mg/1.4mL
Bortezomib · INJECTION · Amneal Pharmaceuticals LLC
No Recall History
Plain English
BORUZU is a injection containing bortezomib at 3.5 mg/1.4mL, taken intravenous. Manufactured by Amneal Pharmaceuticals LLC.
Key Facts
- Brand Name
- BORUZU
- Generic Name
- Bortezomib
- NDC Code (Product)
70121-2484- Manufacturer
- Amneal Pharmaceuticals LLC
- Strength
- 3.5 mg/1.4mL
- Dosage Form
- INJECTION
- Route
- INTRAVENOUS, SUBCUTANEOUS
- Marketing Status
- Application #
- NDA212782
- Drug Class
- Proteasome Inhibitor [EPC]
- Marketing Start
- 09/27/2024
Recall History
No Recall HistoryFrequently Asked Questions
What is BORUZU used for?
BORUZU contains Bortezomib. It is a injection taken intravenous. Consult your doctor for specific uses.
Is BORUZU a controlled substance?
BORUZU is not classified as a controlled substance by the DEA.
What is the generic name for BORUZU?
The generic name for BORUZU is Bortezomib. There are 12 other brand versions of Bortezomib.
What is the NDC code for BORUZU 3.5 mg/1.4mL?
The NDC (National Drug Code) for BORUZU 3.5 mg/1.4mL is 70121-2484, listed by Amneal Pharmaceuticals LLC.